First Trust Advisors
ALNY icon

First Trust Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$82.1M Buy
251,817
+71,357
+40% +$23.3M 0.07% 366
2025
Q1
$48.7M Sell
180,460
-147,322
-45% -$39.8M 0.04% 543
2024
Q4
$77.1M Buy
327,782
+42,211
+15% +$9.93M 0.07% 367
2024
Q3
$78.5M Buy
285,571
+45,024
+19% +$12.4M 0.07% 307
2024
Q2
$58.5M Buy
240,547
+23,174
+11% +$5.63M 0.06% 377
2024
Q1
$32.5M Sell
217,373
-89,320
-29% -$13.3M 0.03% 622
2023
Q4
$58.7M Buy
306,693
+73,203
+31% +$14M 0.06% 393
2023
Q3
$41.4M Sell
233,490
-42,886
-16% -$7.6M 0.05% 471
2023
Q2
$52.5M Sell
276,376
-153,711
-36% -$29.2M 0.06% 433
2023
Q1
$86.2M Buy
430,087
+9,527
+2% +$1.91M 0.1% 278
2022
Q4
$99.9M Sell
420,560
-74,372
-15% -$17.7M 0.12% 237
2022
Q3
$99.1M Buy
494,932
+95,067
+24% +$19M 0.13% 197
2022
Q2
$58.3M Sell
399,865
-2,787
-0.7% -$406K 0.07% 413
2022
Q1
$65.7M Sell
402,652
-104,444
-21% -$17.1M 0.07% 415
2021
Q4
$86M Sell
507,096
-25,190
-5% -$4.27M 0.08% 290
2021
Q3
$101M Buy
532,286
+26,363
+5% +$4.98M 0.11% 237
2021
Q2
$85.8M Buy
505,923
+73,793
+17% +$12.5M 0.09% 285
2021
Q1
$61M Sell
432,130
-130,495
-23% -$18.4M 0.07% 378
2020
Q4
$73.1M Sell
562,625
-162,987
-22% -$21.2M 0.1% 272
2020
Q3
$106M Sell
725,612
-83,954
-10% -$12.2M 0.17% 142
2020
Q2
$120M Sell
809,566
-37,668
-4% -$5.58M 0.21% 115
2020
Q1
$92.2M Buy
847,234
+249,019
+42% +$27.1M 0.21% 107
2019
Q4
$68.9M Sell
598,215
-205,451
-26% -$23.7M 0.12% 237
2019
Q3
$64.6M Sell
803,666
-349,574
-30% -$28.1M 0.12% 216
2019
Q2
$83.7M Sell
1,153,240
-39,255
-3% -$2.85M 0.16% 169
2019
Q1
$111M Buy
1,192,495
+14,439
+1% +$1.35M 0.22% 100
2018
Q4
$85.9M Buy
1,178,056
+241,031
+26% +$17.6M 0.2% 99
2018
Q3
$82M Buy
937,025
+277,259
+42% +$24.3M 0.15% 152
2018
Q2
$65M Buy
659,766
+123,099
+23% +$12.1M 0.13% 151
2018
Q1
$63.9M Sell
536,667
-34,731
-6% -$4.14M 0.15% 133
2017
Q4
$72.6M Sell
571,398
-213,221
-27% -$27.1M 0.17% 117
2017
Q3
$92.2M Buy
784,619
+158,288
+25% +$18.6M 0.24% 80
2017
Q2
$50M Sell
626,331
-67,853
-10% -$5.41M 0.13% 169
2017
Q1
$35.6M Sell
694,184
-44,224
-6% -$2.27M 0.1% 246
2016
Q4
$27.6M Buy
738,408
+317,432
+75% +$11.9M 0.08% 313
2016
Q3
$28.5M Buy
420,976
+3,729
+0.9% +$253K 0.09% 300
2016
Q2
$23.2M Sell
417,247
-43,638
-9% -$2.42M 0.07% 353
2016
Q1
$28.9M Sell
460,885
-762,650
-62% -$47.9M 0.09% 270
2015
Q4
$115M Sell
1,223,535
-338,836
-22% -$31.9M 0.3% 63
2015
Q3
$126M Buy
1,562,371
+6,547
+0.4% +$526K 0.36% 40
2015
Q2
$186M Buy
1,555,824
+301,299
+24% +$36.1M 0.48% 23
2015
Q1
$131M Buy
1,254,525
+396,842
+46% +$41.4M 0.38% 37
2014
Q4
$83.2M Buy
+857,683
New +$83.2M 0.28% 67